Assessment of tobacco and substance use among patients with aluminum phosphide poisoning: A register-based study

Aryan  Haghighi; Hamid  Mohammadi Kojidi; Alireza  Badsar; Habib  Islami; Morteza  Rahbar-Taramsari

doi:10.61882/jcbior.5.1.289

Authors

Aryan Haghighi Razi Clinical Research Development Unit, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
Hamid Mohammadi Kojidi Department of Forensic Medicine and Toxicology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Alireza Badsar Department of Forensic Medicine and Toxicology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Habib Islami Razi Clinical Research Development Unit, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
Morteza Rahbar-Taramsari Department of Forensic Medicine and Toxicology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran https://orcid.org/0000-0003-0950-7599

DOI:

https://doi.org/10.61882/jcbior.5.1.289

Keywords:

Aluminum phosphide, Tobacco, Drug abuse

Abstract

Aluminum phosphide (AlP) poisoning is a major public health concern in several low- and middle-income countries due to its high fatality rate and widespread availability. While its clinical toxicity is well-documented, limited research exists on behavioral risk factors such as tobacco and illicit drug use among affected individuals. This study aimed to assess the prevalence of tobacco and substance use among patients with AlP poisoning and explore its associations with demographic characteristics, clinical outcomes, and mortality. A descriptive cross-sectional study was conducted at Razi Hospital in northern Iran between March 2018 and March 2022. Data from 481 AlP poisoning cases were retrospectively analyzed using structured questionnaires, medical records, and interviews. Sociodemographic variables, substance use history, and clinical outcomes were assessed. Of the 481 patients, 29.7% (n = 143) reported tobacco or illicit substance use. Substance use was significantly more prevalent among males (92.3%), individuals aged 21–40, the self-employed, singles, and those with economic hardship or concurrent alcohol consumption (P < 0.05). Although not statistically significant (P = 0.132), mortality was higher among substance users (46.2%) compared to non-users (38.8%). Tobacco and illicit drug use are common among AlP poisoning patients and are strongly associated with specific sociodemographic factors. Although causality could not be established, substance use may contribute to poorer clinical outcomes. These findings underscore the importance of integrating behavioral screening into AlP poisoning management and highlight the need for targeted prevention strategies in high-risk populations.

References

1. Hadi N, Asfandiyar, Saleem A, Ashraf, Rumman, Ullah Z, et al. Electrocardiographic Patterns as Predictors of Mortality in Aluminum Phosphide Poisoning: A Retrospective Cohort Single-Center Study. Cureus. 2025;17(4):e81713. DOI: 10.7759/cureus.81713 PMID: 40235690

2. Gurjar M, Baronia AK, Azim A, Sharma K. Managing aluminum phosphide poisonings. J Emerg Trauma Shock. 2011;4(3):378-84. DOI: 10.4103/0974-2700.83868 PMID: 21887030

3. Shadnia S, Sasanian G, Allami P, Hosseini A, Ranjbar A, Amini-Shirazi N, et al. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol. 2009;28(4):209-13. DOI: 10.1177/0960327108097194 PMID: 19734272

4. Alnasser S, Hussain SM, Kirdi TS, Ahmed A. Aluminum phosphide poisoning in Saudi Arabia over a nine-year period. Ann Saudi Med. 2018;38(4):277-283. DOI: 10.5144/0256-4947.2018.277 PMID: 30078026

5. Kordrostami R, Akhgari M, Ameri M, Ghadipasha M, Aghakhani K. Forensic toxicology analysis of self-poisoning suicidal deaths in Tehran, Iran; trends between 2011-2015. Daru. 2017;25(1):15. DOI: 10.1186/s40199-017-0181-1 PMID: 28610598

6. Kozak K, Lucatch AM, Lowe DJE, Balodis IM, MacKillop J, George TP. The neurobiology of impulsivity and substance use disorders: implications for treatment. Ann N Y Acad Sci. 2019;1451(1):71-91. DOI: 10.1111/nyas.13977 PMID: 30291624

7. Kojidi HM, Attarchi M, Rahbar-Taramsari M, Badsar A, Faraji N, Rastak Y, et al. Aluminum Phosphide Poisoning in the North of Iran: A Register-based Research. Curr Drug Saf. 2023;18(3):323-334. DOI: 10.2174/1574886317666220627112353 PMID: 35761489

8. de Veld L, Wolberink IM, van Hoof JJ, van der Lely N. The role of tobacco smoking and illicit drug use in adolescent acute alcohol intoxication. BMC Pediatr. 2021;21(1):233. DOI: 10.1186/s12887-021-02710-3 PMID: 34001049

9. Hemovich V, Lac A, Crano WD. Understanding early-onset drug and alcohol outcomes among youth: the role of family structure, social factors, and interpersonal perceptions of use. Psychol Health Med. 2011;16(3):249-67. DOI: 10.1080/13548506.2010.532560 PMID: 21491334

10. Aschengrau A, Grippo A, Winter MR. Influence of Family and Community Socioeconomic Status on the Risk of Adolescent Drug Use. Subst Use Misuse. 2021;56(5):577-587. DOI: 10.1080/10826084.2021.1883660 PMID: 33719860

11. Patrick ME, Wightman P, Schoeni RF, Schulenberg JE. Socioeconomic status and substance use among young adults: a comparison across constructs and drugs. J Stud Alcohol Drugs. 2012;73(5):772-82. DOI: 10.15288/jsad.2012.73.772 PMID: 22846241

12. Rodzlan Hasani WS, Saminathan TA, Ab Majid NL, Miaw Yn JL, Mat Rifin H, Abd Hamid HA, et al. Polysubstance use among adolescents in Malaysia: Findings from the National Health and Morbidity Survey 2017. PLoS One. 2021;16(1):e0245593. DOI: 10.1371/journal.pone.0245593 PMID: 33476329

13. Black N, Noghrehchi F, Yuen WS, Aiken A, Clare PJ, Chan G, et al. Transitions to polysubstance use: Prospective cohort study of adolescents in Australia. Addiction. 2024;119(6):1100-1110. DOI: 10.1111/add.16468 PMID: 38499496

14. Moss HB, Chen CM, Yi HY. Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample. Drug Alcohol Depend. 2014;136:51-62. DOI: 10.1016/j.drugalcdep.2013.12.011 PMID: 24434016

15. Farahani MV, Soroosh D, Marashi SM. Thoughts on the current management of acute aluminum phosphide toxicity and proposals for therapy: An Evidence-based review. Indian J Crit Care Med. 2016;20(12):724-730. DOI: 10.4103/0972-5229.195712 PMID: 28149031

16. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru. 2012;20(1):25. DOI: 10.1186/2008-2231-20-25 PMID: 23351193

17. Mladěnka P, Applová L, Patočka J, Costa VM, Remiao F, Pourová J, et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018;38(4):1332-1403. DOI: 10.1002/med.21476 PMID: 29315692

18. Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203-229. DOI: 10.1002/wps.21073 PMID: 37159360

19. Halladay J, Woock R, El-Khechen H, Munn C, MacKillop J, Amlung M, et al. Patterns of substance use among adolescents: A systematic review. Drug Alcohol Depend. 2020;216:108222. DOI: 10.1016/j.drugalcdep.2020.108222 PMID: 32971420

20. Nada MAA, Elfeky AKEE, Darweesh HAM, Mohamed FKI, Sharif LS, Kandil FS, et al. Correction: The effect of educational programs on parents' knowledge, behavior, and practices regarding aluminum phosphide poisoning and its first-aid measures. BMC Pediatr. 2025;25(1):51. DOI: 10.1186/s12887-025-05404-2 PMID: 39838344